Collectively, these data suggest that circMALAT1 exhibited an oncogenic effect by stabilizing MSI2 proteins, which augments its function leading to the CSCs and is responsible for cisplatin resistance of ESCC. The gene discussed is MSI2; the disease is esophageal squamous cell carcinoma.